Drug withdrawal syndromes-- a literature review.
Drug withdrawal syndromes reportedly have been caused by numerous pharmacological agents, but only a few drugs have been adequately studied in this regard. Criteria for evaluating drug withdrawal syndromes have been proposed. Sedative-hypnotic agents, opiates, corticosteroids, clonidine, tricyclic antidepressant medications and beta-adrenergic blocking agents meet the criteria for such syndromes. Gradual tapering of the dose of these drugs is recommended when therapy must be discontinued. Whether or not other drugs cause rebound reactions is questionable, but caution should be used when discontinuing drugs for which numerous reports of withdrawal syndromes exist.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D003000:Clonidine / Q000009:adverse effects; D000431:Ethanol / Q000009:adverse effects; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D009294:Narcotics / Q000009:adverse effects; D011247:Pregnancy; D011433:Propranolol / Q000009:adverse effects; D011619:Psychotropic Drugs / Q000009:adverse effects; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis* / Q000628:therapy*
D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D000927:Anticonvulsants; D009294:Narcotics; D011619:Psychotropic Drugs; D000431:Ethanol; D011433:Propranolol; D003000:Clonidine